Workflow
财报分析
icon
Search documents
海象新材2025年中报简析:净利润同比增长1099.05%,公司应收账款体量较大
Zheng Quan Zhi Xing· 2025-08-30 23:27
Financial Performance - The company's total revenue for the first half of 2025 was 604 million yuan, a decrease of 12.1% year-on-year [1] - The net profit attributable to shareholders reached 64.95 million yuan, an increase of 1099.05% year-on-year [1] - In Q2 2025, total revenue was 333 million yuan, down 13.72% year-on-year, while net profit attributable to shareholders was 40.27 million yuan, up 823.62% year-on-year [1] - The gross profit margin was 24.94%, a decrease of 4.36% year-on-year, while the net profit margin was 10.76%, an increase of 1264.1% year-on-year [1] - Total operating expenses (selling, administrative, and financial expenses) amounted to 65.53 million yuan, accounting for 10.85% of revenue, a decrease of 18.05% year-on-year [1] Key Financial Ratios - The company's return on invested capital (ROIC) was 3.23% last year, indicating weak capital returns [2] - The historical median ROIC since the company went public is 11.54%, with the worst year being 2023 at 2.93% [1][2] - The company's earnings per share (EPS) was 0.64 yuan, an increase of 1180.0% year-on-year, and the operating cash flow per share was 1.21 yuan, up 81.49% year-on-year [1] Balance Sheet Highlights - Cash and cash equivalents increased to 439 million yuan, a rise of 92.05% year-on-year [1] - Accounts receivable decreased to 277 million yuan, down 17.24% year-on-year, but the accounts receivable to net profit ratio was 553.39% [1][2] - Interest-bearing liabilities decreased to 570 million yuan, a decline of 6.65% year-on-year [1]
东方盛虹2025年中报简析:净利润同比增长21.24%,短期债务压力上升
Zheng Quan Zhi Xing· 2025-08-30 23:27
Core Insights - The company, Dongfang Shenghong, reported a total revenue of 60.916 billion yuan for the first half of 2025, a year-on-year decrease of 16.36%, while the net profit attributable to shareholders increased by 21.24% to 386 million yuan [1] - The company's short-term debt pressure has increased, with a current ratio of 0.45, indicating potential liquidity issues [1] Financial Performance - Total revenue for Q2 2025 was 30.607 billion yuan, down 15.2% year-on-year, with a net profit of 45.079 million yuan, a decline of 37.12% [1] - Gross margin decreased to 10.14%, down 4.46% year-on-year, while net margin improved to 0.64%, an increase of 52.65% [1] - Total expenses (selling, administrative, and financial) amounted to 2.917 billion yuan, representing 4.79% of revenue, up 14.34% year-on-year [1] Key Ratios and Metrics - Earnings per share (EPS) increased by 20% to 0.06 yuan, while operating cash flow per share rose by 39.14% to 0.43 yuan [1] - The company's return on invested capital (ROIC) was reported at 1.48%, indicating weak capital returns, with a historical median ROIC of 4.73% over the past decade [3] - The company has faced two years of losses since its IPO, reflecting a fragile business model [3] Debt and Cash Flow Analysis - The company’s cash flow situation is concerning, with cash and cash equivalents accounting for only 7.25% of total assets and 18.35% of current liabilities [3] - The interest-bearing debt ratio reached 67.24%, and the total interest-bearing debt to average operating cash flow over the past three years was 20.93% [3] - Financial expenses accounted for 71.12% of the average operating cash flow over the past three years, indicating high financial burden [3] Fund Holdings - The largest fund holding Dongfang Shenghong is the Changcheng China Intelligent Manufacturing Flexible Allocation Mixed A fund, which holds 488,100 shares and has recently entered the top ten holdings [4] - The fund has a current scale of 0.85 billion yuan and has seen a 34.33% increase over the past year [4]
百克生物2025年中报简析:净利润同比下降153.47%,三费占比上升明显
Zheng Quan Zhi Xing· 2025-08-30 23:27
建议关注公司现金流状况(货币资金/流动负债仅为23.54%) 证券之星价投圈财报分析工具显示: 业务评价:公司去年的ROIC为5.48%,资本回报率一般。去年的净利率为18.88%,算上全部成本后, 公司产品或服务的附加值高。从历史年报数据统计来看,公司上市以来中位数ROIC为15.21%,投资回 报也很好,其中最惨年份2022年的ROIC为4.68%,投资回报一般。公司历史上的财报相对良好(注:公 司上市时间不满10年,上市时间越长财务均分参考意义越大。)。 商业模式:公司业绩主要依靠研发及营销驱动。需要仔细研究这类驱动力背后的实际情况。 财报体检工具显示: 据证券之星公开数据整理,近期百克生物(688276)发布2025年中报。截至本报告期末,公司营业总收 入2.85亿元,同比下降53.93%,归母净利润-7357.34万元,同比下降153.47%。按单季度数据看,第二季 度营业总收入1.23亿元,同比下降64.78%,第二季度归母净利润-7463.77万元,同比下降196.88%。本报 告期百克生物三费占比上升明显,财务费用、销售费用和管理费用总和占总营收同比增幅达65.76%。 本次财报公布的各项数据 ...
中青旅2025年中报简析:增收不增利,公司应收账款体量较大
Zheng Quan Zhi Xing· 2025-08-30 23:27
Financial Performance - The company reported a total revenue of 4.866 billion yuan for the first half of 2025, an increase of 11.84% year-on-year [1] - The net profit attributable to shareholders was 66.853 million yuan, a decrease of 7.88% compared to the previous year [1] - The gross profit margin was 21.35%, down 11.44% year-on-year, while the net profit margin was 2.0%, a decline of 20.09% [1] - The company’s accounts receivable increased by 22.10% to 2.8 billion yuan, significantly impacting its financial metrics [1] Cash Flow and Debt Analysis - The company’s cash flow per share was only 0.01 yuan, a drastic decrease of 95.78% year-on-year [1] - The company’s cash and cash equivalents accounted for only 7.67% of total assets, indicating potential liquidity issues [3] - The interest-bearing debt ratio reached 35.57%, suggesting a high level of leverage [3] Business Model and Market Position - The company’s return on invested capital (ROIC) was 2.96%, indicating weak capital returns, with a historical median ROIC of 5.29% over the past decade [2] - The business model relies heavily on marketing-driven strategies, which may require further investigation to understand underlying performance drivers [2] Shareholder Information - The largest fund holding in the company is the Guotai Central Enterprise Reform Stock A fund, which holds 600,000 shares and has recently entered the top ten holdings [4]
博闻科技2025年中报简析:增收不增利,存货明显上升
Zheng Quan Zhi Xing· 2025-08-30 23:26
Core Insights - The company reported a total revenue of 28.69 million yuan for the first half of 2025, representing a year-on-year increase of 71.78% [1] - The net profit attributable to shareholders was 14.35 million yuan, showing a significant decline of 63.89% year-on-year [1] - The company's inventory increased substantially, with a year-on-year growth of 115.9% [1] Financial Performance - The second quarter revenue reached 17.06 million yuan, up 77.33% year-on-year, while the net profit for the same period was 8.25 million yuan, down 46.19% year-on-year [1] - Gross margin stood at 5.59%, an increase of 15.78% year-on-year, while net margin decreased by 79.22% to 48.74% [1] - Total selling, administrative, and financial expenses amounted to 12.51 million yuan, accounting for 43.6% of revenue, a decrease of 33.74% year-on-year [1] Cash Flow and Return Metrics - The company reported a negative operating cash flow per share of -0.02 yuan, a decline of 175.12% year-on-year [1] - The return on invested capital (ROIC) for the previous year was 7.41%, indicating average capital returns [2] - The historical median ROIC over the past decade was 5.43%, with a notably low ROIC of 0.67% in 2018 [2] Debt and Financial Health - The company has a healthy cash asset position, but the average operating cash flow over the past three years is -76.71% relative to current liabilities [2] - Financial expenses have been a concern, with the average net cash flow from operating activities over the past three years being negative [2]
勘设股份2025年中报简析:增收不增利,公司应收账款体量较大
Zheng Quan Zhi Xing· 2025-08-30 23:26
Core Viewpoint - The recent financial report of Kuan She Co., Ltd. (603458) indicates a mixed performance with a slight increase in revenue but a significant decline in net profit, raising concerns about the company's financial health and operational efficiency [1] Financial Performance - Total revenue for the first half of 2025 reached 572 million yuan, representing a year-on-year increase of 3.5% [1] - The net profit attributable to shareholders was -97.22 million yuan, a decrease of 24.76% compared to the previous year [1] - In Q2 2025, total revenue was 315 million yuan, up 8.6% year-on-year, while net profit was -77.72 million yuan, down 59.28% [1] Profitability Metrics - Gross margin stood at 20.56%, down 25.5% year-on-year [1] - Net margin was -17.39%, a decline of 17.8% compared to the previous year [1] - The total of selling, administrative, and financial expenses was 110 million yuan, accounting for 19.19% of revenue, a decrease of 23.47% year-on-year [1] Balance Sheet Highlights - Cash and cash equivalents increased to 778 million yuan, up 16.23% year-on-year [1] - Accounts receivable amounted to 2.402 billion yuan, down 5.68% from the previous year [1] - Interest-bearing debt decreased to 1.231 billion yuan, a reduction of 18.63% year-on-year [1] Shareholder Metrics - Earnings per share (EPS) was -0.32 yuan, a decrease of 28.0% year-on-year [1] - Net asset value per share was 9.47 yuan, down 9.91% compared to the previous year [1] - Operating cash flow per share was -0.45 yuan, an improvement of 51.55% year-on-year [1] Debt and Cash Flow Analysis - The company's cash flow situation is considered healthy, with cash assets providing a good buffer against liabilities [2] - The ratio of cash assets to current liabilities is 58.59%, and the average operating cash flow over the past three years relative to current liabilities is 19.74% [2] - The interest-bearing debt ratio has reached 21.58%, indicating a notable level of leverage [2]
福成股份2025年中报简析:营收净利润同比双双增长,公司应收账款体量较大
Zheng Quan Zhi Xing· 2025-08-30 23:26
Group 1 - The core viewpoint of the articles highlights the financial performance of Fucheng Co., Ltd. (600965) in its 2025 interim report, showing a revenue increase of 15.7% year-on-year and a net profit increase of 15.77% [1] - For the second quarter, the company reported a revenue of 267 million yuan, up 17.63% year-on-year, and a net profit of 11.61 million yuan, which is a significant increase of 53.81% [1] - The company's accounts receivable is notably high, with accounts receivable accounting for 132.04% of the latest annual net profit [1] Group 2 - The company's return on invested capital (ROIC) was 2.6% last year, indicating weak capital returns, with a historical median ROIC of 6.4% over the past decade [2] - The net profit margin for the previous year was 5.46%, suggesting that the added value of the company's products or services is average [2] - The company relies heavily on capital expenditure and marketing for its performance, necessitating close scrutiny of the effectiveness of its capital projects [2] Group 3 - The financial health indicators suggest a need to monitor the company's cash flow, with a cash and cash equivalents to current liabilities ratio of only 20.82% [2] - The accounts receivable situation is concerning, as it has reached 132.04% of the profit, indicating potential liquidity issues [2]
国药现代2025年中报简析:净利润同比下降6.46%
Zheng Quan Zhi Xing· 2025-08-30 23:26
Core Viewpoint - The financial performance of Guoyao Modern (600420) for the first half of 2025 shows a decline in both revenue and net profit compared to the previous year, indicating potential challenges in its business operations [1]. Financial Performance Summary - The total operating revenue for the first half of 2025 was 4.878 billion yuan, a decrease of 18.16% year-on-year [1]. - The net profit attributable to shareholders was 672 million yuan, down 6.46% year-on-year [1]. - In Q2 2025, the operating revenue was 2.271 billion yuan, reflecting a 19.95% decline year-on-year, while the net profit was 311 million yuan, a decrease of 19.77% [1]. - The gross profit margin was 36.03%, down 9.08% year-on-year, while the net profit margin increased to 15.79%, up 6.11% year-on-year [1]. - Total expenses (selling, administrative, and financial) amounted to 575 million yuan, accounting for 11.79% of revenue, a decrease of 31.68% year-on-year [1]. - Earnings per share were 0.5 yuan, down 6.46% year-on-year, and operating cash flow per share was 0.5 yuan, a significant decrease of 63.24% year-on-year [1]. Business Evaluation Summary - The company's return on invested capital (ROIC) for the previous year was 8.03%, indicating generally weak capital returns, with a historical median ROIC of 7.9% over the past decade [3]. - The net profit margin for the previous year was 12.18%, suggesting that the company's products or services have a high added value after accounting for all costs [3]. - The company relies heavily on marketing-driven performance, necessitating a thorough examination of the underlying factors driving this performance [3]. - The accounts receivable situation is concerning, with accounts receivable to profit ratio reaching 111.41% [3]. Fund Holdings Summary - The largest fund holding Guoyao Modern is the China Merchants Anying Bond A fund, which holds 1.1427 million shares and has reduced its position [3]. - The fund's current scale is 2.459 billion yuan, with a latest net value of 1.1356 as of August 29, showing a 0.04% increase from the previous trading day and a 6.35% increase over the past year [3].
芭田股份2025年中报简析:营收净利润同比双双增长,盈利能力上升
Zheng Quan Zhi Xing· 2025-08-30 23:26
据证券之星公开数据整理,近期芭田股份(002170)发布2025年中报。截至本报告期末,公司营业总收 入25.43亿元,同比上升63.93%,归母净利润4.56亿元,同比上升203.71%。按单季度数据看,第二季度 营业总收入14.31亿元,同比上升59.94%,第二季度归母净利润2.85亿元,同比上升192.98%。本报告期 芭田股份盈利能力上升,毛利率同比增幅45.71%,净利率同比增幅84.83%。 本次财报公布的各项数据指标表现尚佳。其中,毛利率34.86%,同比增45.71%,净利率17.95%,同比 增84.83%,销售费用、管理费用、财务费用总计1.68亿元,三费占营收比6.61%,同比减35.94%,每股 净资产3.83元,同比增31.68%,每股经营性现金流0.78元,同比增199.47%,每股收益0.47元,同比增 180.75% 证券之星价投圈财报分析工具显示: 业务评价:公司去年的ROIC为9.96%,资本回报率一般。去年的净利率为12.38%,算上全部成本后, 公司产品或服务的附加值高。从历史年报数据统计来看,公司近10年来中位数ROIC为4.04%,中位投资 回报较弱,其中最惨年份 ...
朝阳科技2025年中报简析:营收净利润同比双双增长,公司应收账款体量较大
Zheng Quan Zhi Xing· 2025-08-30 23:26
据证券之星公开数据整理,近期朝阳科技(002981)发布2025年中报。截至本报告期末,公司营业总收 入8.74亿元,同比上升28.05%,归母净利润5244.0万元,同比上升25.21%。按单季度数据看,第二季度 营业总收入4.77亿元,同比上升19.97%,第二季度归母净利润3127.65万元,同比下降5.94%。本报告期 朝阳科技公司应收账款体量较大,当期应收账款占最新年报归母净利润比达371.51%。 业务评价:公司去年的ROIC为10.1%,资本回报率一般。去年的净利率为6.65%,算上全部成本后,公 司产品或服务的附加值一般。从历史年报数据统计来看,公司上市以来中位数ROIC为15.8%,投资回报 也很好,其中最惨年份2021年的ROIC为-4.71%,投资回报极差。公司历史上的财报相对良好(注:公 司上市时间不满10年,上市时间越长财务均分参考意义越大。),公司上市来已有年报4份,亏损年份1 次,需要仔细研究下有无特殊原因。 财报体检工具显示: 建议关注公司现金流状况(货币资金/流动负债仅为79.61%) 建议关注公司应收账款状况(应收账款/利润已达371.51%) 本次财报公布的各项数据指标表 ...